drugset / Trial / NCT04717063
Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the antibacterial efficacy of a commercial mouthwash containing 1.5% hydrogen peroxide in reducing the levels of bacteria in bioaerosols generated by dental prophylaxis.
Timeline
- Start
- 2020-11-16
- Primary completion
- 2020-12-30
- Completion
- 2021-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrogen Peroxide | Small molecule | 1.5 % | — |
Indications
No indication recorded.